Benjamin Greenberg, MD, MHS, FANA, FAAN
Director, Perot Foundation Neurosciences Translational Research Center
O’Donnell Brain Institute
Vice Chair of Translational Research and Strategic Initiatives
Department of Neurology and Neurotherapeutics
Department of Pediatrics
UT Southwestern Medical Center

Dr. Benjamin Greenberg received his Bachelor of Arts degree from Johns Hopkins University and his Masters Degree in Molecular Microbiology and Immunology from the Johns Hopkins School of Public Health in Baltimore, Maryland. He completed his residency in neurology at The Johns Hopkins Hospital and then joined the faculty within the division of neuroimmunology. In January of 2009 he was recruited to the faculty at the University of Texas Southwestern Medical Center where he was named Deputy Director of the Multiple Sclerosis Program and Director of the new Transverse Myelitis and Neuromyelitis Optica Program. Dr. Greenberg is recognized internationally as an expert in rare autoimmune disorders of the central nervous system. His research interests are in both the diagnosis and treatment of transverse myelitis, neuromyelitis optica, encephalitis, multiples sclerosis and infections of the nervous system. He currently serves as the Director of the Neurosciences Clinical Research Center and is a Cain Denius Foundation Scholar.

Brian G. Weinshenker, MD, F.R.C.P.(C)
Neurologist
Mayo Clinic

Brian G. Weinshenker is Professor of Neurology and Consultant at Mayo Clinic, Rochester, MN. Dr. Weinshenker’s major research interests are directed at the understanding of inflammatory demyelinating diseases of the central nervous system including multiple sclerosis, including: 1) natural history of multiple sclerosis; 2) defining clinical and radiologic differential diagnosis of inflammatory myelopathy; 3) classification, diagnosis, and treatment of severe inflammatory demyelinating syndromes of the central nervous system including neuromyelitis optica; and 4) McArdle’s sign, a recently rediscovered clinical sign that is highly specific for multiple sclerosis. He was awarded the John J. Dystel award for multiple sclerosis research in 2011 by the American Academy of Neurology and National Multiple Sclerosis Society (USA).

Stacey L. Clardy, MD PhD FAAN
Neurologist
University of Utah

Dr. Clardy is both clinical and research faculty in the Division of Neuroimmunology within the Department of Neurology. Prior to joining the University of Utah team Dr. Clardy furthered her training with a fellowship in Autoimmune Neurology at the Mayo Clinic. Her training and experience focus on the evaluation and management of autoimmune and paraneoplastic disorders of the nervous system. The spectrum of autoimmune and paraneoplastic neurological disorders intersects all traditional neurology subspecialties, including movement disorders, epilepsy, behavioral/cognitive, neuromuscular, autonomic, demyelinating, and neurooncologic.

Her main clinical interest is devoted to patients affected by antibody-mediated disorders of the nervous system, as well as demyelinating CNS disease, including neuromyelitis optica (NMO) and multiple sclerosis, and Central nervous system complications of rheumatologic disease.

She established the Autoimmune Neurology Clinic at the University of Utah, one of the few clinics in the United States focused on serving this group of patients. Dr. Clardy is also the Director of the Autoimmune Neurology Fellowship program.